| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |